HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yu-Yu Qiu Selected Research

niga-ichigoside F1

2/2018Niga-ichigoside F1 ameliorates high-fat diet-induced hepatic steatosis in male mice by Nrf2 activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yu-Yu Qiu Research Topics

Disease

2Obesity
02/2020 - 12/2016
2Non-alcoholic Fatty Liver Disease
03/2019 - 02/2018
1Body Weight (Weight, Body)
01/2022

Drug/Important Bio-Agent (IBA)

2LipidsIBA
01/2022 - 02/2018
2myricetinIBA
03/2019 - 12/2016
2AntioxidantsIBA
02/2018 - 12/2016
1CholesterolIBA
01/2022
1Triglycerides (Triacylglycerol)IBA
01/2022
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
01/2022
1HDL CholesterolIBA
01/2022
1LDL CholesterolIBA
01/2022
1QuercetinIBA
02/2020
1Thyroid HormonesIBA
02/2020
1MicroRNAs (MicroRNA)IBA
02/2020
1Hypolipidemic Agents (Antihyperlipidemics)IBA
02/2018
1niga-ichigoside F1IBA
02/2018

Therapy/Procedure

1Glycemic Control
01/2022
1Fat-Restricted Diet (Diet, Fat Restricted)
02/2020